Effect of Gemfibrozil Administration on Biliary Lipid Secretion in Hyperlipidemic Patients

References

• Von Bergmann K, Leiss O. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipidemia. Eur J Clin Invest 1984; 14: 150–154
   PubMed Web of Science ®Google Scholar
• Cooper J, Geizerova H, Oliver M F. Clofibrate and gallstones. Lancet 1975; 1: 1083
   PubMed Web of Science ®Google Scholar
• Bateson M C, Maclean D, Ross P E, Bouchier I AD. Clofibrate therapy and gallstone induction. Dig Dis Sci 1978; 23: 623–628
   Google Scholar
• Grundy S M, Ahrens E H, Jr, Salen G, Schreibman P H, Nestel P J. Mechanism of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lip Res 1972; 13: 531–551
   PubMed Web of Science ®Google Scholar
• Pertsemlidis D, Panvelliwalla D, Ahrens E H, Jr. Effect of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology 1974; 66: 565–573
   PubMed Web of Science ®Google Scholar
• Einarsson K, Hellstrom K, Kallner M. The effect of clofibrate on the elimination of cholesterol as bile acid in patients with hyperlipoproteinemia type II and IV. Eur J Clin Invest 1973; 3: 345–351
   PubMed Web of Science ®Google Scholar
• Gemfibrozil: a new lipid lowering agent. Proceedings of an International Symposium held by Parke Davis Company at the Royal Society of Medicine on 15–16 June 1976. Proc R Soc Med 1976; 69(suppl 2)1–120
   Google Scholar
• Newton R S, Krause B R. Mechanism of action of gemfibrozil: comparison of studies in the rat to clinical efficacy. Pharmacological control of hyperlipidemia, R Fears, J R Prou, BarcelonaSpain 1986; 171–186
   Google Scholar
• Kaukola S, Manninen V, Malkonen M. Gemfibrozil in treatment of dislipidemias in middle-aged male survivors of myocardial infarction. Acta Med Scand 1981; 209: 69–73
   PubMedGoogle Scholar
• Frick M H, Elo O, Haapa K, et al. Helsinki heart study: Primary prevention trial with gemfibrozil in middle-aged man with dyslipidemia. N Engl J Med 1987; 317: 1237–1245
   PubMed Web of Science ®Google Scholar
• Nikkilä E A, Ylikahri R, Huttenen J K. Gemfibrozil: effect on serum lipids, lipoproteins postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridemia. Proc Roy Soc Med 1976; 2(suppl 69)58–63
   Google Scholar
• Olsson A G, Rössner S, Walldius G, Carlson L A. Effect of gemfibrozil on lipoprotein concentration in different types of hyperlipoproteinemia. Proc Roy Soc Med 1976; 2(suppl 69)28–31
   Google Scholar
• Saku K, Gartside P S, Hynd B A, Kashyap M L. Mechanism of action of gemfibrozil on lipoprotein metabolism. J Clin Invest 1985; 75: 1702–1712
   PubMed Web of Science ®Google Scholar
• Weintraub M S, Eisenberg S, Breslow J L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyp-erlipoproteinemic individuals: effects of treatment with cholestyramine and gemfibrozil. J Clin Invest 1987; 79: 1110–1119
   PubMed Web of Science ®Google Scholar
• Miller N E, Forde O H, Thelle D S, Mjos O D. The Troms heart study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977; 1: 965–967
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli W P, Hjortland M C, Kannel W B, Dawbert T R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62: 707–714
   PubMed Web of Science ®Google Scholar
• Hall M J, Nelson M L, Russel R I, Howard A N. Gemfibrozil: the effect on biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate. Atherosclerosis 1981; 39: 511–516
   PubMed Web of Science ®Google Scholar
• Leiss O, Von Bergmann K, Gnasso A, Augustin J. Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects. Metabolism 1985; 34: 74–82
   PubMed Web of Science ®Google Scholar
• Block W D, Jarret K J, Levine J B. Use of a single color reagent to improve the automated determination of serum total cholesterol. Automation in analytical chemistry. Mediad Inc., New York 1965; 345–347
   Google Scholar
• Kessler G, Lederer M. Fluorometric measurement of triglycerides. Automation in analytical chemistry. Mediad Inc., New York 1965; 341–344
   Google Scholar
• Warnick G R, Benderson J, Albers J J. Dextran sul-fate Mg2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 1982; 24: 1379–1388
   Google Scholar
• Grundy S M, Metzger A L. A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 1972; 62: 1200–1217
   PubMed Web of Science ®Google Scholar
• Everson G T, Braverman D Z, Johnson M L, Kern F, Jr. A critical evaluation of real time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980; 79: 40–46
   PubMed Web of Science ®Google Scholar
• Fausa O, Skalhegg B A. Quantitative determination of bile acid and their conjugates using thin layer chromatography and a purified 3-alpha-hydroxy-steroid-dehydrogenase. Scand J Gastroenterol 1974; 9: 249–254
   PubMed Web of Science ®Google Scholar
• Roda A, Festi D, Sama C, et al. Enzymatic determination of cholesterol in bile. Clin Chim Acta 1975; 64: 377–381
   Web of Science ®Google Scholar
• Roda A, Geminiani S, Rossi R, Festi D, Roda E, Barbara I. Enzymatic determination of phospho-lipids in bile. Lab J Res Med 1981; 2: 119–122
   Google Scholar
• Abell L L, Levy B B, Brodie B B. Cholesterol in serum. Standard methods of clinical chemistry, D Saligson. Academic Press Inc., New York 1958; Vol. 2: 26–33
   Google Scholar
• Hyden S. A turbidimetric method for determination of higher polyethylene glycols in biological materials. Ann R Agr Coll Swed 1955; 22: 39–149
   Google Scholar
• Van Berge Henegouwen G P, Ruben A, Brandt K H. Quantitative analysis of bile acids in serum and bile, using gas-liquid chromatography. Clin Chim Acta 1974; 54: 49–261
   Web of Science ®Google Scholar
• Carey M C, Small D M. The physical chemistry of cholesterol solubility in bile: relationship to gallstone formation and dissolution in man. J Clin Invest 1978; 61: 998–1026
   PubMed Web of Science ®Google Scholar
• Grundy S M. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J Clin Invest 1975; 55: 69–281
   PubMed Web of Science ®Google Scholar
• Bennion L J, Grundy S M. Effect of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56: 96–101
   Web of Science ®Google Scholar
• Shaffer E A, Small D M. Biliary lipid secretion in cholesterol gallstone disease. The effect of chole-cystectomy and obesity. J Clin Invest 1977; 59: 828–840
   PubMed Web of Science ®Google Scholar
• Miller R G, Jr. Simultaneous statistical inference. 2nd ed. Springer Verlag, New York 1981; 88
   Google Scholar
• Kesäniemi Y A, Grundy S M. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. JAMA 1984; 251: 2241–2246
   PubMed Web of Science ®Google Scholar
• Baired I M, Lewis B, Mill J M. Preliminary observation on the effect of gemfibrozil on the excretion of fecal bile acids. Proc R Soc Med 1976; 69(suppl 2)112–114
   PubMedGoogle Scholar